icrf 193 has been researched along with ku 55933 in 1 studies
| Studies (icrf 193) | Trials (icrf 193) | Recent Studies (post-2010) (icrf 193) | Studies (ku 55933) | Trials (ku 55933) | Recent Studies (post-2010) (ku 55933) |
|---|---|---|---|---|---|
| 155 | 0 | 30 | 164 | 0 | 127 |
| Protein | Taxonomy | icrf 193 (IC50) | ku 55933 (IC50) |
|---|---|---|---|
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | Homo sapiens (human) | 0.458 | |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | Homo sapiens (human) | 0.133 | |
| Serine/threonine-protein kinase mTOR | Homo sapiens (human) | 7.44 | |
| DNA-dependent protein kinase catalytic subunit | Homo sapiens (human) | 1.4943 | |
| Serine-protein kinase ATM | Homo sapiens (human) | 0.191 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Besnard, E; Dulić, V; Fisher, D; Lossaint, G; Piette, J | 1 |
1 other study(ies) available for icrf 193 and ku 55933
| Article | Year |
|---|---|
Chk1 is dispensable for G2 arrest in response to sustained DNA damage when the ATM/p53/p21 pathway is functional.
Topics: Antineoplastic Agents; Ataxia Telangiectasia Mutated Proteins; Bleomycin; Cell Cycle Proteins; Cell Line, Tumor; Cells, Cultured; Checkpoint Kinase 1; Checkpoint Kinase 2; Cyclin B1; Cyclin-Dependent Kinase Inhibitor p21; Diketopiperazines; DNA Damage; DNA-Binding Proteins; Female; G2 Phase Cell Cycle Checkpoints; HCT116 Cells; HeLa Cells; Humans; Immunoblotting; Male; Morpholines; Phosphorylation; Piperazines; Protein Kinases; Protein Serine-Threonine Kinases; Pyrones; RNA Interference; Signal Transduction; Tumor Suppressor Protein p53; Tumor Suppressor Proteins | 2011 |